Shots: ReNeuron to receive £6.0M ($7.9M) upfront, £6.0M ($7.9M) near-term milestones, £8.0M ($10.5M) regulatory milestones and post-launch profit threshold milestones of 5% on annual profit, leading to total milestones £80.0M […]readmore
Tags : CTX
Latest Posts
Categories
Related Topics
AbbVie
Acceptance
Acquire
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Boehringer Ingelheim
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Lilly
Merck
Novartis
P-III
patients
Pfizer
receives
Regeneron
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
Treat
Treatment
US